In the wake of a global health crisis, the National Dental Centre Singapore (NDCS) has spearheaded research to create an innovative antiseptic mouth rinse to diminish the SARS-CoV-2 virus in saliva. This breakthrough, achieved in collaboration with Singapore’s own Pearlie White®, demonstrates a pivotal stride in antiviral oral healthcare products.
A randomized clinical trial conducted by Associate Professor Jaya Seneviratne and his team at the National Dental Research Institute Singapore (NDRIS) in 2020 established the foundational efficacy of mouth rinses containing Cetylpyridinium Chloride (CPC). These commercial mouth rinses were shown to suppress salivary SARS-CoV-2 levels effectively, maintaining this effect for up to six hours post-use. The study, published in the peer-reviewed journal Infection, marks a significant milestone in oral health research.
The success of this trial inspired a joint venture between NDCS and Pearlie White® to develop Pearlie White Defenze™ Antiseptic Fluoride Mouth Rinse. This product marries rigorous scientific research with extensive industry experience.
The partnership between academia and industry is a stellar example of Singapore’s agility in responding to global health emergencies.
The product’s formulation is a blend of science and nature, incorporating CPC with natural ingredients known for their oral health benefits—such as Echinacea, Chamomile, and Tea Tree Oil—while avoiding substances like Alcohol, Parabens, and Sodium Lauryl Sulphate. This formulation strategy signifies a departure from conventional oral care products, aiming for a product that can be incorporated into everyday health regimes.
Pearlie White’s commitment to inclusivity and safety is further reflected in the product being dermatologically tested, halal-certified, and gluten-free. Managing Director Andy Ong expressed pride in the product’s Singaporean origins, “It represents a significant public-private sector achievement with the potential to make a substantial impact on consumer oral health worldwide.”
As Pearlie White prepares for the market introduction of their new antiseptic mouth rinse, the clinical trials spearheaded by Professor Seneviratne’s team will continue to monitor its efficacy and potential applications in dental practices and beyond. This ongoing research may not only influence oral health practices but could also inform strategies against future health crises.
The innovation emerging from the collaboration between NDCS and Pearlie White® stands as a beacon of Singapore’s contribution to public health and its capacity for rapid, effective innovation. As trials progress and the product reaches consumers, it may well become a staple in oral hygiene routines, offering protection against the backdrop of a world still vigilant against viral threats.
This article reflects the current state of research and development in the field of antiviral oral care products and is not an endorsement of Pearlie White Defenze™ Antiseptic Fluoride Mouth Rinse. It aims to provide an informative overview of the advances made in Singapore and their potential global impact.
For more information, please visit: www.pearliewhite.com